Global Fund -WHO Harmonized Country Pharmaceutical Profile
This is a tool to assess the situation analysis of the pharmaceutical sector in a holistic approach. It has been developed and tested by Global Fund and WHO and is being used to identify the strengths and areas which need to be supported in the pharmaceutical sector. During the Global Fund proposal development, this tool needs to be filled in complementarity with disease specific country profile tools. Therefore, in order to address the disease specific PSM programmatic issues, it is recommended to use the Pharmaceutical and Health Product Management Country Profile (Part II) and the Procurement Plan.
Approvisionnement, Assurance Qualité, Fixation des prix, Planification & Budgétisation, Politique
- Sous-catégories Immunisation, Paludisme, Santé reproductive, Tuberculose, VIH/SIDA
- Commodities Diagnostiques, Médicaments, Moustiquaires, Produits de santé reproductive
- Date de mise à jour 2010
- Version First version
- Développé par Global Fund and WHO
- Quand l'utiliser This is a tool to assess the situation analysis of the pharmaceutical sector in a holistic approach. It has been developed and tested by Global Fund and WHO and is being used to identify the strengths and areas which need to be supported in the pharmaceutical sector. During the Global Fund proposal development, this tool needs to be filled in complementarity with disease specific country profile tools. Therefore, in order to address the disease specific PSM programmatic issues, it is recommended to use the Pharmaceutical and Health Product Management Country Profile (Part II) and the Procurement Plan.
- Langues Anglais, Français
- Niveau d'utilisation Central
- Forme PDF
- Amount of training / TA required None
- Inputs & outputs A comprehensive analysis of the pharmaceutical sector, showing strengths and weaknesses that call for support. Good tool for the preapration of the PSM plan.
- Coût Free
- Advantages Unlike the previous PSM plan, these tools address the pharmaceutical issues in a more comprehensive manner.
- Contraintes If the pharmaceutical information is scattered, it may be time consumming to complete the country profile. But once this has been done, it becomes easier to fill in these tools in subsequent years.
- Disponibilité PDF
- Remarques
-
Downloadable files
GF-WHO Harmonized Country Pharmaceutical Profile_en.doc
- Contact Joseph.Serutoke@theglobalfund.org
- Submission date 2011-07-28 11:17:53